BMS, which already has two FDA-approved CAR T-cell therapies, is eyeing entry into the growing in vivo market.
In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...
Bayer AG has struck a deal with Atara Biotherapeutics to jointly work on Atara's CAR-T cell anti-tumour treatments, as the German group firms up its commitment to build a specialist cell and gene ...
Scientists have long suspected connections between heredity and disease, dating back to Hippocrates, who observed certain ...
Developing cardiac inflammatory organoid models incorporating multiple cell lineages is vital for novel therapies.
Researchers at The University of Osaka have discovered precursor T follicular regulatory cells (preTfr), comprising 30-50% of ...
Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...
The 2025 Nobel Prize in Physiology or Medicine has been awarded to a trio of researchers whose work identified and shed light ...
A small but key UK study has found that "cellular immunity" to the pandemic SARS-CoV-2 virus is present after six months in people who had mild or asymptomatic COVID-19 - suggesting they might have ...
A research team at The University of Osaka, joined by Professor Shimon Sakaguchi—the latest Nobel Laureate in Physiology or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback